FDA Panel's "Misinformation" on Antidepressant Use in Pregnancy
The Brian Lehrer Show
00:00
Intro
This chapter explores the FDA expert panel's concerns about the safety of SSRIs during pregnancy and the backlash from medical organizations. It delves into the potential impact of changing warning labels and the challenges of balancing mental health treatment with the health of pregnant women.
Transcript
Play full episode
